Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2008-12-19FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
The FDA approved a supplemental application for bupropion hydrochloride submitted by Apnar Pharma LP.
-
FDA approval · 2008-11-26FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for a generic Bupropion Hydrochloride product from Amneal Pharmaceuticals of New York LLC, enabling …
-
FDA approval · 2008-10-31FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved Apotex Corp's supplemental application for paroxetine hydrochloride (paroxetine HCl), confirming continued approval for the gen…
-
FDA approval · 2008-10-31FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved an original generic application for sertraline hydrochloride by Rising Pharma Holdings, Inc., allowing a generic version of…
-
FDA approval · 2008-10-22FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for fluoxetine from Teva Pharmaceuticals USA, Inc., indicating a modification to the product's a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-10-11FDA Approved: LEXAPRO — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Lexapro (escitalopram) submitted by Allergan, authorizing changes to the drug's labeling.
-
FDA approval · 2008-09-25FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for Fluoxetine hydrochloride from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2008-09-18FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Celexa (citalopram) filed by Allergan, Inc.
-
FDA approval · 2008-08-18FDA Approved: FLUOXETINE — Supplemental Application (Chartwell Governmental & Specialty RX, LLC)
FDA approved a supplemental application for fluoxetine submitted by Chartwell Governmental & Specialty RX, LLC.
-
FDA approval · 2008-08-18FDA Approved: FLUOXETINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental ANDA for Fluoxetine by Teva Pharmaceuticals USA, Inc., authorizing a generic version of fluoxetine. The action f…
-
FDA approval · 2008-08-15FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Actavis Pharma, Inc.)
The FDA approved the original ANDA for bupropion hydrochloride from Actavis Pharma, Inc., enabling a generic product to reach the market. Th…
-
FDA approval · 2008-08-14FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2008-08-13FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc., a generic antidepressant.
-
FDA approval · 2008-08-13FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Citalopram from Torrent Pharmaceuticals Limited.
-
FDA approval · 2008-08-13FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride from Teva Pharmaceuticals USA, Inc., granting approval of an updated or …
-
FDA approval · 2008-08-13FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for trazodone hydrochloride (generic) under ANDA 071524.
-
FDA approval · 2008-08-11FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
The FDA approved a supplemental application for trazodone hydrochloride from Apotex Corp, enabling a generic version to be marketed for the …
-
FDA approval · 2008-08-11FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for trazodone hydrochloride (Apotex Corp). The approval pertains to a supplemental filing updating t…
-
FDA approval · 2008-07-16FDA Approved: SERTRALINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approves a supplemental abbreviated new drug application (ANDA) for sertraline from Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals …
-
FDA approval · 2008-07-14FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved Lannett's supplemental application for doxepin hydrochloride, confirming a generic version is approvable. The product will carr…
-
FDA approval · 2008-07-10FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for bupropion hydrochloride from Amneal Pharmaceuticals of New York LLC under ANDA077415.
-
FDA approval · 2008-07-09FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride XL, resulting in modifications to labeling/indications for the product.
-
FDA approval · 2008-07-02FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals, Inc.'s supplemental application for sertraline hydrochloride (generic sertraline), authorizing the a…
-
FDA approval · 2008-07-02FDA Approved: CITALOPRAM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for citalopram from Hikma Pharmaceuticals USA, resulting in an approved addition to the product's au…
-
FDA approval · 2008-07-02FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Citalopram hydrobromide from Aurobindo Pharma Limited, enabling continued marketing of this …